#
Title
1

Lessons From the Lab: Burning feet: A Potpourri of Discussion Around a Seemingly Simple Problem

2

Azathioprine versus Mycophenolate Mofetil, Comparing Effectiveness for Treatment of Generalized Myasthenia Gravis

3

AANEM Guideline on Diagnostic and Screening Tests for Small Fiber Neuropathy

4

Ultrasound-Guided Nerve Hydrodissection for Peripheral Entrapment Neuropathies

5

Webinar: Approach to Immunization in Neuromuscular Disorders

6

AANEM Podcast Featuring ANF: Too Young for ALS? Mikey Stone’s Story and the EMG That Changed Everything

7

Lessons From the Lab: A patient with hand weakness–is a good clinical examination all that you need?

8

Multisystem Proteinopathies

9

Lessons From the Lab: A Patient With Fasciculations Here, There, EVERYWHERE!

10

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 2

11

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 1

12

Monoclonal Gammopathy Associated Myopathies

13

AANEM Crossfire Podcast: Should Neuromuscular Ultrasound be Routinely Used in the Diagnosis of CIDP?

14

Lessons From the Lab: Pediatric EMG Pearls on an Unusual Pediatric Case

15

AANEM Crossfire Podcast: Should Serum Neurofilament Light Chain or NfL be Incorporated into Routine ALS Clinical Practice?

16

AANEM Crossfire Podcast: Should a Combined Sensory Index be Used in Every Case of Suspected Carpal Tunnel Syndrome?

17

Lessons From the Lab: A Numb Foot Could be a Numb-er of Things

18

AANEM Crossfire Podcast: The Balance Between Diagnostic Testing and Clinical Care

19

Lessons From the Lab: LIVE at AANEM – A lively discussion about a strange arm problem.

20

Lessons From the Lab: A woman with shoulder weakness – just a rotator cuff problem?

21

Lessons Learned in the EMG Lab: Elevating EMG Practice Through International Exchange

22

Updates on Neuralgic Amyotrophy

23

Electromyography Referrals Principles and Practices for Optimizing EMG Orders

24

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies: Part 2

25

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1

26

Lessons From the Lab: Progressive Leg Weakness After Running

27

Postural Orthostatic Tachycardia Syndrome (POTS)

28

Lessons From the Lab: Ulnar Neuropathy

29

Global Standardization of EMG and Nerve Conduction Study Training: Challenges and Collaborative Solutions

30

International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Diseases

31

HMGCR Immune-Mediated Necrotizing Myopathy: Review of Clinical Features and Update on Treatment

32

Lessons From the Lab: Breaking Down Atypical Neuropathy

33

Advancing the Field: Perspectives from Nerve Conduction Technologists

34

Training Program Partnership at AANEM

35

Lessons From the Lab: L5 Radiculopathy

36

Lessons From the Lab: Unilateral Tongue Weakness

37

A Discussion About the ADHERE Study: Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod in Patients With CIDP

38

The Evolving Role of Muscle and Nerve Biopsies in Neuromuscular Diagnosis: A Discussion With Experts

39

Understanding the Safety Factor in Neuromuscular Junction Transmission: A Conversation with Dr. Kyle Mahoney

40

Lessons From the Lab: Patient With Trouble Raising Arm: More Than Rotator Cuff?

41

Building Successful Clinical Trial Programs in Neuromuscular Medicine: Insights from Private Practice Experts

42

Lessons From the Lab: A Patient With Poly Neuropathy & Ulnar Neuropathy

43

CIDP in Focus: Evolving Diagnosis, Treatment, and Future Directions - A Discussion with Global Experts

44

Paraproteinemic Neuropathies

45

Advances in the Therapeutic Landscape of Anti-MAG Neuropathy

46

Clinical and Neurophysiological Recovery of Ulnar Nerve Conduction Block at the Elbow

47

Acquired Hyperexcitable Peripheral Nerve Disorders: Clinical and Laboratory Features, Therapeutic Responses, and Long-Term Follow-Up

48

Lessons From the Lab: LIVE 2 Webinar Recording (Aug. 2024)

49

AANEM EDX Lab Accreditation

50

Promoting Quality EDX in Legislation

51

Lessons From the Lab: Approach to a Patient With Weakness

52

Fraud and Abuse

53

Career Phenotypes Part 4 - Perspective from a Clinician in Private Practice

54

Lessons From the Lab: Clinical, EDX, and Practical Approaches for Progressive Weakness

55

Career Phenotypes Part 3 - Perspectives from Neuromuscular Providers on Subspecialty Selection

56

Career Phenotypes Part 2 - Perspective from a Clinician Researcher

57

Career Phenotypes Part 1 - Perspectives from Clinician Educators in Academic Practice

58

Lessons From the Lab: Navigating EDX with Drs. Rubin and Cartwright

59

Comparison of Muscle Ultrasound and Needle Electromyography Findings in Neuromuscular Disorders

60

The Role of AI in NM and EDX Medicine

61

Lessons From the Lab: Peripheral Neuropathy

62

Lessons From the Lab: LIVE Webinar Recording (March 2024)

63

A Discussion of Three Challenging Electrodiagnostic Cases

64

Lessons From the Lab: Electrodiagnostic Assessment of Polyneuropathy

65

Lessons From the Lab: Subacute Lower Extremity Weakness

66

Lessons From the Lab: Evaluation of Patients With Suspected Motor Neuron Disease

67

Diagnosis and Management of Metabolic Myopathies

68

The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy

69

Lessons From the Lab: EMG Discussion with Professor Erik Stalberg

70

Respiratory Considerations in Patients With Neuromuscular Disorders

71

Lessons From the Lab: Scapular Winging

72

ALS Treatment Landscape

73

Lessons From the Lab: A Patient With Bilateral Foot Numbness

74

Lessons From the Lab: EDX & NMUS Approaches to a Patient With Dyspnea

75

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

76

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

77

Lessons From the Lab: How to Approach Suspected Ulnar Neuropathy in the EMG Laboratory

78

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

79

Lessons From the Lab: EDX Approach to Radiculopathy

80

Lessons From the Lab

81

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis, Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) Trials

82

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis (MG), Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials

83

Musculoskeletal Mimics of Cervical Radiculopathy

84

Musculoskeletal Mimics of Cervical Radiculopathy

85

Spinal Muscular Atrophy (SMA) and its Management

86

Spinal Muscular Atrophy and its Management

87

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

88

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

89

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force—Second Revision

90

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force

91

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

92

Neuromuscular Complications of Immune Checkpoint Inhibitors

93

Neuromuscular Complications of Immune Checkpoint Inhibitors

94

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

95

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

96

Clinical Features of LRP4/Agrin-Antibody–Positive Myasthenia Gravis

97

Clinical Features of LRP4/agrin-antibody Positive Myasthenia Gravis

98

COVID-19 and Neuromuscular Disorders

99

Approach to Dysphagia With Focus on Neuromuscular Disorders

100

Approach to Dysphagia With Focus on Neuromuscular Disorders

101

Porphyric Neuropathy Part II

102

Porphyric Neuropathy Part I

103

Porphyric Neuropathy Part II

104

Porphyric Neuropathy Part I

105

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

106

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

107

Autonomic Neuropathies

108

Autonomic Neuropathies

109

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

110

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

111

COVID-19 and Neuromuscular Disorders

112

Electrodiagnostic Approach to Patients Presenting With Respiratory Symptoms

113

Anterior Interosseous Nerve Syndrome

114

Rehabilitative Approach to ALS Patients highlighting Eye-Controlled, Power Wheelchair Performs Well for ALS Patients

115

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part II.

116

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part I

117

Nutritional Neuropathies

118

Quality Improvement Projects in the EMG laboratory

119

Long-term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis

120

Ultrasound-Guided Treatment of Peripheral Entrapment Neuropathies

121

Effect of Shoulder and Elbow Position on Ulnar Nerve Conduction

122

Thymectomy may not be Associated With Clinical Improvement in MuSK Myasthenia Gravis

123

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis

124

Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy

125

Needle Electromyography and Histopathologic Correlation in Myopathies

126

Muscle Biopsy EMG Correlation

127

Long‐Term Neuromuscular Outcomes of West Nile Virus Infection A Clinical and Electromyographic Evaluation of Patients With a History of Infection

128

Electrodiagnostic Errors Contribute to Chronic Inflammatory Demyelinating Polyneuropathy Misdiagnosis

129

Amyloid TTR Treatment Studies

130

Subcutaneous Versus Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies - A Meta-Analysis

131

Complex and Simple Clinical Reaction Times Are Associated with Gait, Balance, and Major Fall Injury

132

Acute Nutritional Axonal Neuropathy

133

The Value Transformation of Health Care: Impact on Neuromuscular and Electrodiagnostic Medicine

134

Hereditary Myopathies With Early Respiratory Insufficiency in Adults

135

Thoracic Outlet Syndrome Part 1 and Part 2

136

Evaluation of Patients With Refractory Chronic Inflammatory Demyelinating Polyneuropathy

137

International Consensus Guidance for Management of Myasthenia Gravis: Executive Summary

138

Optimizing Muscle Selection for Electromyography in Amyotrophic Lateral Sclerosis

139

Association of Inclusion Body Myositis With T Cell Large Granular Lymphocytic Leukaemia

140

Transthyretin Amyloid Neuropathy has Earlier Neural Involvement but Better Prognosis than Primary

141

POEMS vs CIDP

142

Gene Editing in Monogenic Diseases With CRISPR

143

Presymptomatic ALS Genetic Counseling and Testing: Experience and Recommendations

144

Randomized Trial of Thymectomy in Myasthenia Gravis

145

Normative Data Task Force: Establishing High-Quality Reference Values for NCS

146

Rapid Screening for Inflammatory Neuropathies by Standardized Clinical Criteria

147

Sensory Neuronopathies

148

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy

149

Critically re-evaluating a common technique: Accuracy, reliability, and confirmation bias of EMG

150

Can Mycophenolate Mofetil be Tapered Safely in MG. A Retrospective, Multicenter Analysis

151

Paraproteinemic Neuropathies

152

Inherited Etiologies of Rhabdomyolysis

153

Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis

154

Clinical Presentation and Acquired Causes of Rhabdomyolysis

155

Patterns of Clinical and Electrodiagnostic Abnormalities in Early Amyotrophic Lateral Sclerosis

156

NCS technique for ulnar neuropathy

157

NCS Technique for Ulnar Neuropathy

158

Neuralgic Amyotrophy (Parsonage-Turner): Etiology, Treatment, Natural History

159

Neuralgic Amyotrophy (Parsonage-Turner): Presentation & Diagnosis

160

Whole Exome Sequencing

161

Next Generation Sequencing and its Impact on Neuromuscular Medicine

162

ALS Onset is Influenced by the Burden of Rare Variants in Known ALS Genes

163

Muscle Intrusion as a Potential Cause of Carpal Tunnel Syndrome

164

Dermatomyositis and Autoantibodies by Dr. Andrew L. Mammen

165

Necrotizing Myopathies by Dr. Andrew L. Mammen

166

Antisynthetase syndrome and myositis by Dr. Andrew L. Mammen

167

Pathokinesiology of Duchenne Muscular Dystrophy

168

Clinical Value of Motor Nerve Conduction Velocity Determination

169

Diagnosis and Treatment of Limb Girdle and Distal Dystrophies, Evidence-Based Guideline

170

Electrodiagnosis of Ulnar Neuropathy at the Elbow (Une): a Bayesian Approach.

171

Myotonic Dystrophy Health Index: Initial Evaluation of a Disease-Specific Outcome Measure

172

Vasculitic Neuropathies

173

Improving Referring Physicians' Understanding of EMG Reports When Qualifying Radiculopathies

174

Exome Sequencing by Michael Shy, MD and Stephan Zuchner, MD

175

Spinal muscular atrophy: Development and Implementation of Potential Treatments

176

Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead by Dr. Blackhall

177

Myasthenia Gravis and the use of IVIg and Therapeutic Plasma Exchange by Dr. Vern Juel

178

Inherited Neuropathies: Clinical Overview and Update by Drs. Christopher Klein and Michael Shy

179

Electrodiagnosis of ulnar neuropathy at the elbow (Une): A bayesian approach

180

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis by Dr.Steven Greenberg

181

Diagnostic Ultrasound of the Fibular (Peroneal) Nerve by Drs. Francis Walker and Michael Cartwright

182

Diagnostic Ultrasound of the Ulnar Nerve and Ulnar Neuropathy at the Elbow by Drs. Francis Walker and Michael Cartwright

183

Diagnostic Ultrasound of the Median Nerve and Median Neuropathy at the Wrist by Drs. Francis Walker and Michael Cartwright

184

Paraneoplastic Neuromuscular Disorders

185

Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies

186

Chronic pain as a manifestation of potassium channel-complex autoimmunity by Dr. Christopher Klein

187

Diagnosis of the Limb-girdle Muscular Dystrophies by Dr. Kate Bushby

188

The Thoracic Outlet Syndromes

189

The Role of Exercise in Amyotrophic Lateral Sclerosis

190

The Distal Hereditary Motor Neuropathies by Dr. Mary Reilly

191

Myokymic and Neuromyotonic Discharges by Drs. Ludwig Gutmann, Jasper Daube, and Devon Rubin

192

Evidence Based Guideline on Treatment of Painful Diabetic Neuropathy by Vera Bril, MD

193

Cardiomyopathies in Muscular Dystrophies by Christopher Spurney, MD

194

Treatment-induced Diabetic Neuropathy: A Reversible Painful Autonomic Neuropathy

195

ALS may be caused by impaired protein recycling and degradation by Teepu Siddique, MD

196

Good Nutritional Control May Prevent Polyneuropathy After Bariatric Surgery by Pariwat Thaisetthawatkul, MD and P. James Dyck, MD

197

Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies by Michael Shy, MD

198

Evaluation and management of foot drop by John D. Stewart, MBBS,MRCP(UK),FRCP

199

A randomized study of alglucosidase alfa in late-onset Pompe's disease by Robert Leshner, MD, and Paula Clemens, MD

200

Post-surgical Inflammatory Neuropathy by P. James B. Dyck, MD and Nathan Staff, MD

201

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

202

A Novel Autoantibody in Patients with Necrotizing Myopathy by Andrew L. Mammen, MD, PhD

203

Pharmacokinetics of IVIg and Outcome in GBS by Krista Kuitwaard, MD

204

A Practical Approach to the Metabolic Myopathies; Diagnosis and treatment: Glycogen Storage Myopathy

205

Practical Approach to the Metabolic Myopathies: Diagnosis and Treatment-FAOD and Mitochondrial Myopathies by Mark A. Tarnopolsky, MD, PhD

206

Genetics, Pathology, and Treatment of Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

207

Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

208

Pulsed High-dose Dexamethasone Versus Standard Prednisolone Treatment for CIDP (PREDICT study): a double-blind, randomized, controlled trial by Ivo N. van Schaik, MD, PhD

209

Influenza Vaccination Safety for Patients with Myasthenia Gravis

210

Inclusion Body Myositis

211

Evaluation and Treatment of the Inflammatory Myopathies

212

Toxic, Including Statin, Myopathies

213

Is There an Increased Risk of GBS Following Influenza Vaccines or Other Vaccines?

214

A Discussion about the Distal Symmetric Polyneuropathy Practice Guidelines by John D. England, MD

215

Ascorbic Acid for Charcot–Marie–Tooth Disease by Joshua Burns, PhD

216

Abnormal EMG Findings During Muscle Activation

217

Abnormal Needle EMG Findings with the Muscle at Rest

218

Needle Electromygraphy

219

Needlestick Injuries Among Electromyographers

220

Risk of Hematoma Following Needle EMG Study in Anticoagulated Patients and Patients on Antiplatelet Therapy

221

Stem Cell Replacement Research for ALS

222

Pediatric Electromyography

223

Myofibrillar Myopathies

224

Lessons Learned in Single Fiber EMG

225

Early Days of Single Fiber EMG

226

IgG1 Antibodies to Acetylcholine Receptors in ‘Seronegative’ MG

227

Limb Girdle Muscular Dystrophy

228

Histopathology of Neuropathy

229

Lifetime Course in Myasthenia Gravis

230

Critical Illness Polyneuropathy and Myopathy

231

Sacral Plexopathies

232

Identifying Lumbosacral Radiculopathies

233

Pathokinesiology of Duchenne Muscular Dystrophy

234

Autosomal-Recessive and X-linked Forms of Hereditary Motor and Sensory Neuropathy in Childhood

235

Immunotherapy in Guillain-Barre Syndrome

236

The Therapy of Congenital Myasthenic Syndromes

237

Safety of Nerve Conduction Studies in Patients with Implanted Cardiac Devices

238

Chronic Inflammatory Polyradiculoneuropathy

239

Electromyographic and Magnetic Resonance Imaging to Predict Lumbar Stenosis, Low-back Pain, and No Back Symptoms by Andrew J. Haig, MD

240

Accuracy of Repetitive Nerve Stimulation for Diagnosis of Cramp-Fasciculation Syndrome

241

An Unusual Variant of Acute Idiopathic Polyneuritis

242

The Influence of the Reference Electrode on CMAP Configuration

243

Uremic Neuropathy: Clinical Features and New Pathophysiologic Insights

244

Experimental Allergic Neuritis

245

Sporadic Onset of Erythermalgia

246

Peripheral Neuropathy in Krabbe Disease

247

Radiculopathy and the Herniated Lumbar Disc

248

Sural Neuropathy: Etiologies and Predisposing Factors

249

Is Exercise Necessary with Repetitive Nerve Stimulation in Evaluating Patients with Suspected Myasthenia Gravis

250

Myelin Protein Zero Mutation His39Pro

251

Interferon-Alpha Beta–Mediated Innate Immune Mechanisms in Dermatomyositis

252

Electrophysiological Findings in a Cohort of Old Polio Survivors

253

Clinical Value of Motor Nerve Conduction Velocity Determination

254

Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathies by P. James B. Dyck, MD

255

Rehabilitation Management of Peripheral Neuropathy

256

The Natural History of Primary Lateral Sclerosis

257

Facioscapulahumeral Muscular Dystrophy by Rabi Tawil, MD

258

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy by Phillip Chance, MD and Mark Hannibal, MD

259

Axillary Pain as a Heralding Sign of Neoplasm Involving the Upper Thoracic Root